Skip to main content
. 2014 Dec 31;7:53–64. doi: 10.2147/CLEP.S73728

Table S3.

Characteristics of symptomatic patients in the coronary CTA cohort and patients in the randomly selected sample from the Western Denmark Cardiac Computed Tomography Registry, 2008–2012

Coronary CTA cohort overall
(n=18,899)
Random samplea
(n=250)
Male sex 10,169 (53.8) 107 (42.8)
Age, yearsb 58 (50–66) 56.5 (48–63)
Family history of premature CAD 7,353 (38.9) 97 (38.8)
Current lipid-lowering therapy 5,883 (31.1) 79 (31.6)
Current medical treatment for hypertension 6,532 (34.6) 84 (33.6)
Smoking status (current or former) 9,504 (50.3) 131 (52.4)
Diabetes 1,035 (5.5) 33 (13.2)
Previous PCI 166 (0.9) 0
Previous cardiac surgery 156 (0.8) 1 (0.4)
Previous myocardial infarction 193 (1.0) 0
Height (cm)b 171 (165–178) 171 (158–184)
Weight (kg)b 78 (67–88) 78 (56–100)
Creatinine level, μmol/Lb 73 (63–83) 72 (55–89)
Systolic blood pressure, mmHgb 140 (126–151) 138 (112–164)
Diastolic blood pressure, mmHgb 81 (75–90) 80 (65–95)
Left ventricular ejection fractionb 60 (60–60) 60 (60–60)
Angina type (if any)
 Typical angina 1,764 (9.4) 22 (8.8)
 Atypical angina 5,844 (30.9) 78 (31.2)
 Unspecific chest pain 4,760 (25.2) 58 (23.2)
 Dyspnea 916 (4.8) 8 (3.2)
 Unknown 5,615 (29.7) 84 (33.6)
Priority
 Acute 78 (0.4) 2 (0.8)
 Subacute 755 (4.0) 2 (0.8)
 Elective 17,209 (91.1) 230 (92.0)
 Unknown 857 (4.5) 16 (6.4)
Kilo-electron voltb 100 (100–120) 120 (100–120)
Radiation dose c c
Iodine concentration, mg/mLb 350 (350–370) 370 (350–370)
Contrast volume, mLb 80 (70–90) 77.5 (70–90)
Preprocedural beta-blocker 11,991 (63.4) 164 (65.6)
Heart rhythm
 Sinus rhythm 17,794 (94.2) 229 (91.6)
 Atrial fibrillation 108 (0.6) 2 (0.8)
 Other 85 (0.4) 2 (0.8)
 Unknown 912 (4.8) 17 (6.8)
Heart rate (bpm)b 59 (54–64) 60 (55–65)
Cardiac CT quality
 Good 14,304 (75.7) 184 (73.6)
 Moderate 1,897 (10.0) 20 (8.0)
 Nonevaluable 828 (4.4) 18 (7.2)
 Unknown 1,870 (9.9) 28 (11.2)
CACS (Agatston) resultb 0 (0–90) 0 (0–75)
Coronary CTA result
 Normal 12,550 (66.4) 164 (65.6)
 Nonobstructive CAD 2,213 (11.7) 39 (15.6)
 1-vessel obstructive CAD 2,012 (10.6) 19 (7.6)
 2-vessel obstructive CAD 673 (3.6) 7 (2.8)
 3-vessel/LM obstructive CAD 312 (1.7) 6 (2.4)
 Only CACS performed 427 (2.3) 6 (2.4)
 Unknown 712 (3.7) 9 (3.6)
Consequence of coronary CTA results
 Nothing further 8,673 (45.9) 96 (38.4)
 Medical treatment 3,313 (17.5) 39 (15.6)
 Referral to invasive coronary angiography 3,216 (17.0) 42 (16.8)
 Referral to myocardial perfusion imaging 632 (3.3) 10 (4.0)
 CACS is too high – referral to further testing 157 (0.8) 1 (0.4)
 Referral to other noninvasive diagnostic testing 399 (2.1) 9 (3.6)
 Unknown 2,509 (13.4) 53 (21.2)

Notes:

a

250 randomly selected symptomatic patients who underwent coronary CTA at three university cardiac centers (Aarhus, Aalborg, and Odense) and two nonuniversity cardiac centers (Lillebaelt Hospital-Vejle and Hospital of Southwestern Denmark-Esbjerg);

b

values in median ± interquartile range;

c

was not estimated due to differences in registered dose units.

Abbreviations: CACS, coronary artery calcium scoring; CAD, coronary artery disease; CT, computed tomography; CTA, computed tomography angiography; LM, left main; PCI, percutaneous coronary intervention.